Protagonist Therapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 16.64, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Protagonist Therapeutics Inc in Jun 30 2026 quarter, has decreased to 22 days, compared to 67 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 371 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 2545 to 2667.

What is Receivable Turnover Ratio?
What is Protagonist Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PTGX Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	3749.17 %	99.03 %	-95.64 %	0.79 %	33.09 %
Receivable Turnover Ratio (TTM)	16.64	5.45	261.45	1435.45	-
PTGX's Total Ranking	# 2667	# 2545	# 10	# 2343	#
Accounts Receivable average collection period days	22	67	1	0	-
Seq. Receivable Change	-75 %	44249.59 %	-79.25 %	-	-
Seq. Revenue Change	278.72 %	657.94 %	57.83 %	-15.04 %	-80.42 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 112
Healthcare Sector	# 372
Overall Market	# 2667

Receivable Turnover Ratio Statistics
High	Average	Low
185.28	22.13	-0.03
(Jun 30 2025)		(Sep 30 2019)

PTGX Company Profile • Back to PTGX Efficiency Comparisons • Compare PTGX Receivables Turnover Ratio to its Competitors

Financial Statements
Protagonist Therapeutics Inc 's Accounts Receivable	$ 13 Millions	Visit PTGX's Balance sheet
Protagonist Therapeutics Inc 's Sales TTM	$ 282 Millions	Visit PTGX's Income Statement
Sources of PTGX's Revenues		Visit PTGX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PTGX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PTGX's Growth Rates	PTGX's Roa	PTGX's Inventory Turnover Ratio	PTGX's Dividend Comparisons
PTGX's Profitability Ratios	PTGX's Roi	PTGX's Asset Turnover Ratio	PTGX's Dividend Growth
PTGX's Valuation Ratios	PTGX's Roe	PTGX's Financial Strength Ratios	PTGX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Fortrea Holdings Inc	56.65	$ 2,676.500 Millions	$ 47.250 Millions
Humacyte Inc	52.69	$ 30.074 Millions	$ 0.571 Millions
Brookdale Senior Living Inc	47.66	$ 3,050.697 Millions	$ 64.009 Millions
National Vision Holdings Inc	44.61	$ 2,033.426 Millions	$ 45.586 Millions
Meiragtx Holdings Plc	40.72	$ 397.501 Millions	$ 9.762 Millions
Nature s Sunshine Products inc	39.24	$ 491.790 Millions	$ 12.532 Millions
Bioadaptives Inc	35.76	$ 0.026 Millions	$ 0.001 Millions
Lifevantage Corp	35.05	$ 180.947 Millions	$ 5.162 Millions
Electrocore Inc	34.09	$ 36.527 Millions	$ 1.072 Millions
Innovative Eyewear Inc	31.49	$ 3.412 Millions	$ 0.108 Millions
Mangoceuticals Inc	31.43	$ 0.315 Millions	$ 0.010 Millions
Cv Sciences Inc	31.22	$ 12.066 Millions	$ 0.387 Millions
Jaguar Health Inc	30.23	$ 27.815 Millions	$ 0.920 Millions
Invo Fertility Inc	30.20	$ 7.531 Millions	$ 0.249 Millions
Innovage Holding Corp	27.53	$ 989.707 Millions	$ 35.951 Millions
Metagenomi Therapeutics Inc	25.05	$ 13.561 Millions	$ 0.541 Millions
Sonida Senior Living Inc	22.59	$ 525.973 Millions	$ 23.283 Millions
U S Physical Therapy Inc	22.40	$ 812.203 Millions	$ 36.251 Millions
Nutriband Inc	22.15	$ 1.618 Millions	$ 0.073 Millions
Ginkgo Bioworks Holdings Inc	20.32	$ 111.863 Millions	$ 5.506 Millions
Lineage Cell Therapeutics Inc	20.02	$ 13.083 Millions	$ 0.654 Millions
Hims and Hers Health Inc	19.65	$ 2,578.494 Millions	$ 131.228 Millions
Lipocine Inc	18.36	$ 1.569 Millions	$ 0.085 Millions
Nrx Pharmaceuticals Inc	17.25	$ 3.394 Millions	$ 0.197 Millions
Polomar Health Services, Inc.	17.19	$ 3.172 Millions	$ 0.185 Millions
Anika Therapeutics Inc	16.70	$ 121.370 Millions	$ 7.266 Millions
Vireo Growth Inc.	16.69	$ 511.706 Millions	$ 30.659 Millions
Lifemd Inc	16.48	$ 163.363 Millions	$ 9.915 Millions
Protagonist Therapeutics inc	15.97	$ 281.992 Millions	$ 17.661 Millions
Neuraxis Inc	15.53	$ 5.316 Millions	$ 0.342 Millions

Date modified: 2026-09-11T09:50:26+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.